Published 22 October 2008, doi:10.1136/bmj.a2197
Cite this as: BMJ 2008;337:a2197

News

Growth of drug resistant HIV in China is "worrying," says AIDS institute

Jane Parry

1 Hong Kong

The first 150 words of the full text of this article appear below.

Resistance of HIV to drugs is increasing in China, Zhiwei Chen, director of the University of Hong Kong’s AIDS Institute, has said. Only seven of the more than 20 antiretroviral drugs on the market are available in China.

"The drug resistant mutations are not unique to Chinese people and therefore are consistent with those found in other countries," he said. "However, the frequency of drug resistance after two years of treatment is high. The unique feature is that a significant portion of treated patients have developed AIDS due to the drug resistant mutations and the lack of second line drugs."

At the same time, he said, the profile of China’s epidemic was changing as infections are spreading beyond historically high risk groups and into the general population, including vertical transmission from mother to child.

Research published in Nature (doi:10.1038/455609a) by Professor Chen and colleagues from China and the . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Access jobs at BMJ Careers
Whats new online at Student BMJ